Trial · NCT01307462
Adverse events25
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 25
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Cavitary Pulmonary Lesion | Respiratory, thoracic and mediastinal disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| other | Edema | General disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| other | Alanine aminotransferase increased | Investigations | Treatment (BOS Therapy) | 1 | 36 | 1 |
| other | Hyperglycemia | Metabolism and nutrition disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| other | Hypertension | Vascular disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| other | Lung infection | Respiratory, thoracic and mediastinal disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| other | Rash maculopapular | Skin and subcutaneous tissue disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| other | Thrombocytopenia | Investigations | Treatment (BOS Therapy) | 1 | 36 | 1 |
| other | Ventricular tachycardia | Cardiac disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| serious | Edema limbs | General disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| serious | Pulmonary nodules | Respiratory, thoracic and mediastinal disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| serious | Hypoxia | Respiratory, thoracic and mediastinal disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| serious | Fever | General disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| serious | Presyncope | Nervous system disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| serious | Pneumonia | Respiratory, thoracic and mediastinal disorders | Treatment (BOS Therapy) | 3 | 36 | 3 |
| serious | Neutropenia | Blood and lymphatic system disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| serious | Pain | Musculoskeletal and connective tissue disorders | Treatment (BOS Therapy) | 2 | 36 | 2 |
| serious | Pneumonitis | Respiratory, thoracic and mediastinal disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| serious | Fluid overload | Respiratory, thoracic and mediastinal disorders | Treatment (BOS Therapy) | 1 | 36 | 1 |
| serious | Lung infection | Respiratory, thoracic and mediastinal disorders | Treatment (BOS Therapy) | 3 | 36 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01307462/events